research Imaging prostate cancer (PCa) with [99m Tc(CO)3 ]finasteride dithiocarbamate
In this study, researchers developed a new prostate cancer imaging agent, a [99m Tc]tricarbonyl complex derived from finasteride, which demonstrated high radiochemical purity and significant uptake in the prostate of a rat model, suggesting its potential for noninvasive prostate cancer imaging.